Jourabchi Medical Corporation – Trademark Portfolio
Entity Type: 03
Jourabchi Medical Corporation holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include JOUR HAIR & SKIN INSTITUTE. The owner is based in Beverly Hills, CA.
9730 Wilshire Blvd, Suite 215
Beverly Hills, CA 90212
Showing of trademarks Trademarks
Trademark Classifications
Jourabchi Medical Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Jourabchi Medical Corporation have?
Jourabchi Medical Corporation has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Jourabchi Medical Corporation file in?
Jourabchi Medical Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Jourabchi Medical Corporation's most well-known trademarks?
Jourabchi Medical Corporation's registered trademark portfolio includes well-known marks such as JOUR HAIR & SKIN INSTITUTE. These are among 1 currently registered trademark in the portfolio.
What is Jourabchi Medical Corporation's trademark registration success rate?
Jourabchi Medical Corporation has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.